Every year at least 1.5 million people suffer adverse effects from medication. These problems occur because people misunderstand labels, are unaware of drug interactions, or otherwise use medication improperly. The Food and Drug Administration's Safe Use Initiative seeks to identify preventable medication risks and develop solutions to them. The IOM held a workshop to discuss the FDA's Safe Use Initiative and other efforts to improve drug labeling and safety.
1 Front Matter; 2 1 Introduction; 3 2 FDA Safe Use Initiative; 4 3 Over-the-Counter Products; 5 4 Initiatives to Advance Patient-Centered Drug Safety; 6 5 Identifying Activities Around Which to Build Partnerships for Patient-Centered Drug Safety; 7 6 How Can the Lessons of Health Literacy Be Used to Build Patient-Centered Outcomes for Safe Use?; 8 References; 9 Appendix A: Acronyms; 10 Appendix B: Workshop Agenda; 11 Appendix C: Workshop Speaker Biosketches
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Population Health and Public Health Practice, Roundtable on Health Literacy, Melissa G. French, Alexis Wojtowicz
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Population Health and Public Health Practice, Roundtable on Health Literacy, Joe Alper
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Population Health and Public Health Practice, Roundtable on Health Literacy, Joe Alper
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Population Health and Public Health Practice, Roundtable on Health Literacy, Joe Alper
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Population Health and Public Health Practice, Roundtable on Health Literacy, Joe Alper
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Population Health and Public Health Practice, Roundtable on Health Literacy, Alexis Wojtowicz, Steve Olson
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Population Health and Public Health Practice, Roundtable on Health Literacy, Joe Alper